Transmission and Risks of Antibiotic Resistance in Tilapia Gut Microbiome
Center of Medicine · 23.04.2026 · 2 (2) · 71-81
DOI: 10.65591/com-71-2026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Center of Medicine, online erschienen am 23.04.2026. Verfasst von Adeel Asghar. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The escalating global demand for animal-derived protein has driven the expansion of aquaculture, especially tilapia (Oreochromis spp.) farming. This review examines the impact of unregulated antibiotic use in tilapia aquaculture on the emergence and proliferation of antibiotic resistance genes (ARGs) within its gut microbiome. A comprehensive analysis of existing literature reveals that ARGs conferring resistance to tetracyclines, sulfonamides, β-lactams, and fluoroquinolones are prevalent in tilapia gut microbiomes. These genes pose critical risks to aquatic ecosystems and public health, particularly through transmission along the food chain and contamination of surrounding environments. Key findings from the literature include the identification of ARGs such as tetA, sul1, and blaTEM, which are often associated with mobile genetic elements, facilitating their spread. The review highlights the need for regulatory frameworks, responsible antibiotic use, and alternative health management practices to mitigate the risks associated with ARG dissemination.
Zitieren
APA
Asghar, A. (2026). Transmission and Risks of Antibiotic Resistance in Tilapia Gut Microbiome. Center of Medicine, 2(2), 71-81. https://doi.org/10.65591/com-71-2026
Vancouver
Asghar A. Transmission and Risks of Antibiotic Resistance in Tilapia Gut Microbiome. Center of Medicine. 2026;2(2):71-81. doi:10.65591/com-71-2026
BibTeX
@article{Asghar2026,
author = {Asghar, Adeel},
title = {Transmission and Risks of Antibiotic Resistance in Tilapia Gut Microbiome},
journal = {Center of Medicine},
year = {2026},
volume = {2},
number = {2},
pages = {71--81},
doi = {10.65591/com-71-2026}
}
EUVIMED